23andMe Holding Co. (ME) - Long-Term Debt to Capital

The market dynamics of 23andMe Holding Co. (ME) reflect the consequences of a deep crisis triggered by the failure of subscription services and the threat of bankruptcy, with the indicator standing at 0.93. This leader in genetic research relies on global authority in DNA diagnostics. The business is integrating sustainable components into its test kits and strictly protecting the privacy of biodata, merging scientific progress with the principles of sustainable development.

This indicator calculates the proportion of long-term borrowings relative to the organization's equity. The metric determines the business's degree of dependence on external financing and its long-term solvency. For 23andMe Holding Co. (ME), this is a critical marker due to the exhaustion of resources from the old sales model and a liquidity deficit. Restructuring requires strict control over borrowed capital. Analyzing the ratio of long-term liabilities to equity allows for an assessment of the company's bankruptcy risks.